A tissue valve formed in vivo.
The ATS 3f® Aortic Bioprosthesis is here. A revolutionary approach to a replacement heart valve, it’s the only bioprosthesis that facilitates the natural formation of the valve in vivo.

Open to exceptional performance and more?
Surgeons are adopting the ATS Open Pivot® Heart Valve – and its fundamentally unique design – in impressive numbers.

Now hear this. 
Most mechanical heart valves make a clicking sound that's audible. So if you'd rather not have your friend hear your heart beat at lunch, consider the ATS Open Pivot Heart Valve. It has been shown to be quieter than all other valves. In fact, some recipients have reported they cannot hear it at all.^2,6,9,10

Annual Shareholder Meeting 4:00 pm, Thursday, May 8, 2008.
Location: Dorsey and Whitney LLP, 50 South 6th Street, Minneapolis, MN 55402, 612-343-7963.

A minimally-invasive, maximally-effective symposium. 
ATS Medical begins its first "Frontiers in Cryoablation" symposium series at AATS on May 11, 2008. Topics featured include current techniques, robotics and the future of minimally invasive cryoablation. The event is co-sponsored by ATS and Intuitive Surgical.

Greater than 90% success rate demonstrated after stand-alone atrial fibrillation procedures using the ATS CryoMaze ^TM system.
The strengths of the stand-alone procedure are that it can be done through a small incision, is appealing to patients and provides clinical results similiar to the original cut-and-sew Maze.  Read more.

James L. Cox, M.D. appointed as Medical Director
Dr. Cox, an authority in the surgical treatment of atrial fibrillation and one of the groundbreaking researchers on the ATS 3f tissue valve technologies, is uniquely qualified to support the company's efforts in surgical ablation and heart valve therapy. Read more.